Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

By afschroeder • November 23, 2025

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025 Nov 22. doi: 10.1021/acsnano.5c14753. Epub ahead of print. PMID: 41273281.

Tags: General Internal Medicine, immune adjuvant nanocarrier, immune tolerance, immunotherapy, lipid nanoparticle, mRNA, Nano Medicine, Pancreatic ductal adenocarcinoma (PDAC), Post Doc, Publications, reprogramming, tumor microenvironment

Primary Care Practice Productivity and Efficiency: Qualitative Evaluation of a Novel Clinic-Based Measure

McCleskey SG, Khodyakov D, Nelson KM, Curtis I, Newberry SJ, Tran LD, Fihn SD, Wagner TH, Rubenstein LV. Primary Care Practice Productivity and Efficiency: Qualitative[...]

Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study

Lawrence D, Marshall KF. Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study. BMC[...]

2026 AAPM&R Annual Assembly Abstracts

2026 AAPM&R Annual Assembly Abstracts. PM R. 2026 Nov;18 Suppl 3:S1-S175. doi: 10.1002/pmrj.70262. PMID: 43006536.